Ohio State University Comprehensive Cancer Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ohio State University Comprehensive Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9375
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University, is a healthcare institute that offers medical and academic education services. The institute provides education, research, and patient care services. Its services comprise cancer diagnosis, treatment and prevention, clinical services, genetic counselling services, clinical research, research programs and lab services, among others. OSUCCC provides clinical services in therapeutic areas of benign hematology, genitourinary, gastrointestinal, sarcoma and cancer genetics, among others. The institute provides services through a network of medical oncologists, surgical oncologists, radiologists, pathologists, nurses, radiation oncologists and researchers. OSUCCC is headquartered in Columbus, Ohio, the US.

Ohio State University Comprehensive Cancer Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 10
Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 11
Evotec Enters into Research Agreement with Ohio State University 12
Ohio State University Comprehensive Cancer Center – Key Competitors 13
Ohio State University Comprehensive Cancer Center – Key Employees 14
Ohio State University Comprehensive Cancer Center – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Research And Development 16
Aug 11, 2017: Ohio State Cancer Researchers Validate a Clinical Test For Fusion Genes 16
Government and Public Interest 17
Feb 19, 2018: Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer 17
Dec 11, 2017: Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Key Facts 2
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ohio State University Comprehensive Cancer Center, Deals By Therapy Area, 2012 to YTD 2018 8
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 10
Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 11
Evotec Enters into Research Agreement with Ohio State University 12
Ohio State University Comprehensive Cancer Center, Key Competitors 13
Ohio State University Comprehensive Cancer Center, Key Employees 14

List of Figures
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ohio State University Comprehensive Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ohio State University Comprehensive Cancer Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intrinsic Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery; prosthesis for partial anulus replacement; and anular clos …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Direct Energy Marketing Ltd:企業の戦略的SWOT分析
    Direct Energy Marketing Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Alterna Savings and Credit Union Limited:企業の戦略・SWOT・財務情報
    Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report Summary Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Indeck Energy Services Inc:企業の戦略的SWOT分析
    Indeck Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Siamab Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Siamab Therapeutics Inc (Siamab Therapeutics), formerly Sialix Inc, is a biopharmaceutical company that focuses on the development of novel medicines targeting cancer-specific carbohydrate antigens. Its ST1 program targets a tumor associated carbohydrate antigen present in solid tumors. Siam …
  • Nationwide Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Zayo Group LLC (ZAYO):企業の財務・戦略的SWOT分析
    Zayo Group LLC (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Qaf Limited
    Qaf Limited - Strategy, SWOT and Corporate Finance Report Summary Qaf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Simona AG (SIM):企業の財務・戦略的SWOT分析
    Summary Simona AG (Simona) is a chemical company that manufactures and distributes chemicals and thermoplastic products. The company offers products such as pipes and fittings, semi-finished products, and finished parts, among others. Its semi-finished plastics include profiles, plates, rods, and we …
  • Ontario Power Generation Inc.:企業の戦略・SWOT・財務分析
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務分析
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WInckworth Sherwood LLP:企業の戦略的SWOT分析
    WInckworth Sherwood LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nippon Express Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Implenia AG:戦略・SWOT・企業財務分析
    Implenia AG - Strategy, SWOT and Corporate Finance Report Summary Implenia AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆